(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 11.99% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 27.62%.
Iradimed's revenue in 2026 is $83,814,000.On average, 4 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,199,771,645, with the lowest IRMD revenue forecast at $1,142,454,619, and the highest IRMD revenue forecast at $1,246,057,316.
In 2027, IRMD is forecast to generate $1,318,649,509 in revenue, with the lowest revenue forecast at $1,252,691,468 and the highest revenue forecast at $1,372,719,763.